Abstract
Subunit rotation within the F1 catalytic sector of the ATP synthase has been well documented, identifying the synthase as the smallest known rotary motor. In the membrane-embedded FO sector, it is thought that proton transport occurs at a rotor/stator interface between the oligomeric ring of c subunits (rotor) and the single-copy a subunit (stator). Here we report evidence for an energy-dependent rotation at this interface. FOF1 was expressed with a pair of substituted cysteines positioned to allow an intersubunit disulfide crosslink between subunit a and a c subunit [aN214C/cM65C; Jiang, W. & Fillingame, R. H. (1998) Proc. Natl. Acad. Sci. USA 95, 6607–6612]. Membranes were treated with N,N′-dicyclohexyl-[14C]carbodiimide to radiolabel the D61 residue on less than 20% of the c subunits. After oxidation to form an a–c crosslink, the c subunit properly aligned to crosslink to subunit a was found to contain very little 14C label relative to other members of the c ring. However, exposure to MgATP before oxidation significantly increased the radiolabel in the a–c crosslink, indicating that a different c subunit was now aligned with subunit a. This increase was not induced by exposure to MgADP/Pi. Furthermore, preincubation with MgADP and azide to inhibit F1 or with high concentrations of N,N′-dicyclohexylcarbodiimide to label most c subunits prevented the ATP effect. These results provide evidence for an energy-dependent rotation of the c ring relative to subunit a.
H+-transporting, FOF1-ATP synthases (reviewed in refs. 1–5) are found in the membranes of eubacteria, mitochondria, and chloroplasts, where they catalyze the synthesis of ATP from ADP and Pi during oxidative- or photo-phosphorylation. The F1 sector, which contains the catalytic nucleotide binding sites for ATP synthesis, can be removed from the membrane as a water-soluble complex that functions as an ATPase. The FO sector remains embedded within the membrane and, in the absence of F1, conducts passive H+ transport across the bilayer. The minimal subunit composition of FOF1 is represented by the Escherichia coli synthase, in which F1 has five subunits with the stoichiometry α3β3γδɛ, and FO has three subunits with the stoichiometry ab2c9–12 (6).
Data from many experimental approaches support the general structural model for FOF1 shown in Fig. 1. For the F1 sector, high-resolution structures are available (7–9). The arrangement of subunits in FO is supported by studies with electron microscopy (10) and atomic force microscopy (11, 12). A recent low-resolution x-ray structure for an F1c10 subcomplex from yeast mitochondrial synthase (13) supports the oligomeric packing of c subunits in a ring, as well as the interactions of γ and ɛ with the polar surface of the ring, as indicated by earlier genetic and subunit crosslinking studies (14–17).
ATP synthase uses the transport of H+ (or in some cases Na+, see ref. 18) down a transmembrane, electrochemical gradient to drive net ATP synthesis. Under certain conditions, this coupling process can run in reverse as an ATPase-driven proton (or sodium) pump. The mechanism by which the ATP synthase catalyzes efficient, reversible energy coupling between vectorial ion transport and the chemical reactions of ATP synthesis/hydrolysis has been a major focus of research in bioenergetics. The binding change mechanism provides a model that best accommodates a broad range of experimental results (19, 20). It states that energy from proton transport through FO indirectly drives net ATP synthesis by inducing cyclical conformational changes between tight substrate binding and product release at three alternating, cooperative catalytic sites on F1 (21, 22). It further proposes that these binding changes are driven by the rotation of an asymmetric core (γ in Fig. 1) relative to the three surrounding catalytic subunits (β) (23).
The structure of F1 at atomic resolution showed that γ determines the conformational states of the three catalytic subunits (7), consistent with a rotary mechanism. Subsequent studies with isolated F1-ATPase (24–26) documented catalysis-dependent rotation of γ relative to the catalytic β subunits. A disulfide-crosslinking approach indicated that rotation of γ also occurs in membrane-bound FOF1 during ATP hydrolysis (27) and synthesis (28). Finally, it was shown that, during ATP hydrolysis, ɛ also moves with γ as part of the central rotor in F1 (29) as well as in membrane-bound FOF1 (30).
In coupling proton transport to ATP synthesis, most recent models predict that subunit rotation also occurs within FO (see refs. 1 and 31–33). The two motors, F1 and FO, are thought to share a common rotor (γɛc9–12) and a peripheral stator (b2δ) so that proton-driven rotation in FO forces γ to rotate within F1, thereby driving the binding changes required for ATP synthesis (Fig. 1). Recent experiments indicate that the c ring moves with γɛ as part of the rotor in FOF1. Coupled functions of E. coli FOF1 were not blocked by an ɛ-c disulfide linkage (34) nor by the combined γ-ɛ-c disulfide linkages (35). With detergent-extracted E. coli FOF1, anchored to a solid surface by affinity tags on the α subunits, an actin filament attached to the c ring was observed to rotate by fluorescence microscopy (36). However, the functional significance of this observation is controversial (37), because rotation was insensitive to specific inhibitors of FO function. Furthermore, the results suggest a rotation of the c ring relative to the immobilized α3β3 complex, but do not provide information regarding possible rotation relative to other FO subunits. The first direct indication of relative subunit rotation within FO has come from a recent crosslinking study. Exchange of c subunits at the interface of the c ring with b2 indicates rotation of the c ring vs. b2, but again it was not possible to demonstrate energy-dependent rotation (38).
Extensive genetic studies (ref. 39 and reviewed in refs. 32 and 40) have long suggested that subunits a and c function together to transport protons. Rotation of the c ring relative to subunit a could explain how a single copy of a can coordinate this function with multiple copies of c. Detailed models for such a rotary transport mechanism have been presented (5, 24, 31, 41–45) but, as yet, there is no direct evidence that the c ring rotates relative to subunit a.
Here we focus on the interface between subunit a and the c ring, with the goal of testing whether energy-dependent subunit rotation may occur. Our strategy required the ability to form an a–c disulfide crosslink as a means of identifying the particular c subunit that is adjacent to subunit a, combined with an ability to asymmetrically tag the c subunits. An energy-dependent change in the amount of label associated with the c subunit that can be trapped in the a–c crosslinked product then would indicate a rotation of the c ring relative to subunit a. A recent exhaustive topological study involving intersubunit disulfide crosslinking of pairs of substituted cysteine identified points of contact between subunit a and an adjacent subunit c (43). One such contact point involved the aN214C/cM65C cysteine pair, which we chose for our study because of its high crosslinking yield (43). As a means of tagging the c subunits, we chose minimal labeling by N,N′-dicyclohexyl-[14C]-carbodiimide ([14C]DCCD). Subsequent formation of the a–c crosslink in membrane-bound FOF1 showed that the c subunit in the a–c crosslinked product was largely protected from reaction with [14C]DCCD relative to other c subunits. However, exposure to conditions for ATP-driven catalytic turnover before crosslinking resulted in a significant increase in 14C in the a–c band. These results provide evidence for an energy-dependent rotation of the c ring relative to subunit a.
Experimental Procedures
Materials.
N-ethylmaleimide (NEM), p-trifluoro-methoxyphenylhydrazone (FCCP), ATP, ADP, asolectin, taurodeoxycholic acid, and sodium azide were from Sigma. p-Aminobenzamidine dihydrochloride was from Aldrich. Phenylmethylsulfonyl fluoride was from American Bioanalytical. [14C]DCCD (≈54 mCi/mmol) and 125I-labeled IgG (goat) against rabbit Ig were obtained from Amersham Pharmacia. SYPRO orange dye was from Molecular Probes. Poly(vinylidene difluoride) blotting membranes were from Invitrogen. Polyacrylamide gels for SDS/PAGE (Tris-HCl Ready gels, 4–15% acrylamide) were from BioRad. Pyruvate kinase (rabbit) and lactate dehydrogenase (pig) (each 10 mg/ml in 50% glycerol) were from Roche Diagnostics. Polyclonal rabbit antibodies against subunits a (46) and c (47) were provided by R. H. Fillingame, University of Wisconsin, Madison. Other reagents and chemicals were of the highest grade available.
Plasmids and E. coli Strains.
Dr. Fillingame's laboratory kindly supplied plasmids pYZ201, pYZ217 (pYZ201 containing cQ42C; ref. 15), and pDF163 constructs containing the combined mutations aN214C/cM65C (43) or aN214C/cQ42C/cM65C (constructed by Weiping Jiang, University of Wisconsin, Madison). To allow optimal overexpression of FOF1 containing these mutations, the mutant uncBE genes (for subunits a and c, respectively) were transferred from the above constructs into the high copy number construct pJW1, which encodes the genes for all eight subunits of FOF1 (48). Each pDF163 construct was first converted to a pYZ201 construct by inserting the 6.95-kb SphI fragment from wild-type pYZ201 into pDF163's unique SphI site, in the desired orientation (uncBEFHAGDC). The 4.4-kb HindIII fragment (uncBEFHAG′) of each mutant pYZ201 was then used to replace the same wild-type fragment in pJW1. All cloning procedures followed standard protocols. The final clones, pJW1-cQ42C, pJW1-aN214C/cM65C, and pJW1-aN214C/cQ42C/cM65C, were transformed into the expression strain AN887, in which the chromosomal unc operon is inactivated (49). Cells were grown in volumes up to 12 liters in defined medium with appropriate supplements (50), including 0.05–0.1 mg ampicillin/ml, 40% Luria broth, 60 mM glucose, and 1% (vol/vol) glycerol.
Preparation of Membranes.
All steps were done at 4°C, and the pH of each buffer was adjusted at 4°C unless otherwise noted. Membranes were prepared as described (48), stopping after the final wash with buffer containing p-aminobenzamidine. Using purified FOF1 as a standard on SDS/PAGE, stained α and β subunits and immunodetection of subunit a all indicated that FOF1 accounted for ≈50% of total membrane protein. F1-depleted membranes were prepared by exposure to 2 mM Tris⋅HCl, 1 mM EDTA, pH 8.0, with subsequent collection of the membranes by ultracentrifugation. These steps were repeated once, with final resuspension of membranes in MTGMg8 buffer [50 mM Mops-Tris/10% glycerol (vol/vol)/2 mM MgCl2, pH 8.0, room temperature]. This procedure removed >97% of the ATPase activity of the membranes.
Reaction of Membranes with [14C]DCCD and Induction of an Intersubunit, a–c Disulfide Crosslink.
Aliquots of [14C]DCCD in toluene (53.9 μCi/ml) were dried by using a Savant Speedvac, dissolved at ≈1 mM in dry DMSO, and stored at −20°C. Membranes (1 mg protein/ml) were treated with [14C]DCCD (10–100 μM, as noted) in MTGMg8 buffer for up to 2 h at room temperature. Aliquots were removed for immediate coupled-enzyme assays of ATPase. An aliquot also was taken to determine total covalent 14C labeling of proteins as described below. Immediately after reaction with [14C]DCCD, aliquots were diluted to 0.5 mg/ml with MTGMg8 buffer containing additional MgCl2 (5 mM final) and 2 μM p-trifluoro-methoxyphenylhydrazone (FCCP) (except as noted). For most samples, an equal volume of buffer containing either ADP/Pi or ATP was added with vortexing (4 mM final ADP/Pi or ATP). An additional variation was the addition of ADP/azide (1 mM each, final) during the second hour of DCCD treatment, followed by dilution with buffer containing ATP as above. For ATP synthesis conditions, 5 mM or 12 mM MgCl2 was used, FCCP was omitted, and samples were preincubated with succinate (2.5 mM) for 4 min to establish a transmembrane proton motive force. ADP and Pi (4 mM/20 mM final) were then added and the sample was incubated for 2–3 min at room temperature. Finally, I2 was added (50 μM final), and samples were incubated for 10 min to induce a–c crosslinking. To maintain consistency in the oxidation potential, I2 was diluted to 1 mM with MTGMg8 from a 0.2 M stock in dry ethanol just before addition to each sample. Each reaction was quenched by mixing a 7:3 volume ratio of sample with 4× gel sample buffer (51) containing 5 mM NEM to block cysteines.
SDS/PAGE, SYPRO Orange Staining, and Detection of Relative 14C Incorporation.
Samples (typically 8 μg protein/lane) were electrophoresed (51) on a 4–15% polyacrylamide gradient gel. The gel was soaked in water for 10 min, then stained with 50 ml of SYPRO orange [1:5,000 dilution in 7.5% glacial acetic acid (vol/vol)] for 45 min. The gel was destained with 7.5% (vol/vol) acetic acid for 25 min, and then placed in water for 30 min. Protein bands with bound SYPRO orange were imaged by scanning the gel with a STORM 860 (Molecular Dynamics) in blue fluorescent mode. The gel was then vacuum-dried on filter paper and exposed to a low-energy storage phosphor screen (Molecular Dynamics) for 40–120 h to detect 14C-containing bands. The exposed screen was then scanned on the STORM 860 in the phosphorimage mode at 650 nm. IMAGEQUANT 5.1 software (Molecular Dynamics) was used for data analysis. For analysis of 14C label in components of the a–c band, a gel slice containing the band was macerated and incubated for 2 h at 30°C with a minimal volume of 1× gel sample buffer containing β-mercaptoethanol and 50 mM DTT. The sample was then centrifuged and the supernatant was loaded on a 4–15% Ready gel for separation of proteins. The gel was stained with SYPRO orange to reveal residual, unreduced a–c product as well as a- and c-subunit bands. The gel was then dried and exposed to a low-energy storage phosphor screen for ≈210 h to quantitate 14C.
Detection of Subunits a and c by Immunoblotting.
Electrophoresis was performed as above, with 4 μg of membrane protein loaded per lane. Protein bands were transferred to a poly(vinylidene difluoride) membrane as described (27), with 0.25 A of constant current for 75 min. Immunoblotting followed a previous protocol (30). Incubation with anti-a or anti-c rabbit antibody (1:5,000) was for 2 h. Incubation with 125I-labeled anti-rabbit-Ig antibody was for 1.5 h. After the final rinse, the blot was dried and exposed to a standard phosphor screen (Molecular Dynamics) for 20–24 h. The exposed screen was scanned and analyzed as noted above.
Other Assays.
To determine total covalent incorporation of 14C into proteins after treatment of membranes with [14C]DCCD, protein was precipitated with deoxycholate and trichloroacetic acid (52), the pellet was washed with 0.5 ml of cold trichloroacetic acid (10%, wt/vol) and resuspended in gel sample buffer lacking reductant. Aliquots were then taken for scintillation counting and protein determination. Control experiments with FOF1 liposomes (not shown) confirmed that all FOF1 subunits were precipitated and recovered equally by this procedure. For liquid scintillation counting of 14C, each sample was added to a vial containing 4 ml of Biosafe-II scintillant and 0.5 ml of water, then counted in a Beckman LS-6500. Protein was determined by a modified Lowry assay (52). ATPase activity was measured at 30°C, pH 8, with a spectrophotometric, coupled-enzyme assay as described (30). Assay conditions included 6 mM MgCl2, 5 mM ATP, 10 μM p-trifluoro-methoxyphenylhydrazone (FCCP), and 5 mM KCN. In some experiments, 0.5% lauryl dimethylamine oxide was added to assays to uncouple F1 from FO (53) and thus determine whether any inhibition of ATPase was caused by direct modification of F1 subunits by [14C]DCCD. The uncoupled F1-ATPase activity was essentially unaffected by treatment of membranes with 10 μM [14C]DCCD for 2 h, but was inhibited ≈5% by treatment with 100 μM [14C]DCCD for 0.5 h.
Results
Iodine was used to induce crosslinking of aN214C to cM65C in E. coli membranes. The identity of the a–c crosslink band on SDS/PAGE was confirmed by immunoblotting using the same antibodies against a (Fig. 2) and c (data not shown) as used by Jiang and Fillingame (43). Incubation with 50 μM I2 for 10 min (>97% crosslinking; Fig. 2, lane 2 and Table 1) was much more effective than incubation for 1 h with copper phenanthroline (<40% crosslinking; ref. 43).
Table 1.
DCCD treatment* | Efficiency of a–c crosslinking† |
---|---|
None | >97% |
10 μM, 2 h‡ | 96.5% (±0.4%) |
100 μM, 0.5 h | 81.4% (±0.7%) |
Similar experiments with [14C]DCCD showed labeling of 1.8 c/FOF1 for 10 μM [14C]DCCD and 9 c/FOF1 for 100 μM [14C]DCCD (Table 2).
Crosslinking efficiency (±SD) was estimated from immunoblot detection of subunit a (see Fig. 2). Controls using varied amounts of nonoxidized sample established that the assay provided a linear response to subunit a for the amounts remaining in oxidized samples.
Exposure to MgATP before crosslinking had no significant effect on the yield of a–c product.
With the ability to crosslink subunit a to a properly aligned c subunit, our next goal was to obtain differential labeling of the c subunits so that the proximal c subunit could be distinguished from others in the c ring. It had been previously reported that the cQ42C substitution in the subunit's polar loop allowed rapid [14C]NEM labeling of about 60% of c subunits in FOF1, whereas the other 40% was labeled at a much slower rate (54). Based on the possibility that subunit a might in part determine this biphasic labeling, we treated FOF1 liposomes containing the aN214C/cM65C/cQ42C mutations with [14C]NEM. As expected (55), controls with aN214C/cM65C-FOF1 liposomes showed that the membrane-embedded Cys residues were much less reactive toward [14C]NEM than was cQ42C. Consequently, the yields of a–c crosslinking with aN214C/cM65C/cQ42C-FOF1 liposomes were not significantly decreased by labeling a fraction of c subunits at cQ42C. However, even under mild conditions that labeled only one cQ42C/FOF1, there was no evidence of asymmetry in the 14C content of c subunits relative to the specific c subunit that could form the a–c crosslink upon oxidation.
As an alternative approach, we reasoned that c-subunit residues at the a/c interface might be less accessible to modification by hydrophobic reagents than those exposed to lipids (see Fig. 1). To test this possibility, we treated the enzyme with [14C]DCCD to label c subunits at cD61. This residue appears to reside near the center of the bilayer (2, 56), one α-helical turn from the cM65C residue used to form the a–c crosslink. Incubation of membranes containing the aN214C/cM65C mutant pair with 10 μM [14C]DCCD for 2 h resulted in the labeling of 1.8 c subunits per FOF1 (Table 2). The distribution of 14C label among protein bands on SDS/PAGE is shown in Fig. 3A. High specificity for labeling c subunits is evident, as the c band accounted for >90% of all 14C incorporated. A small amount of 14C was present at the position of a–c even in nonoxidized samples (Fig. 3A, black trace), but immunoblotting indicated that <5% of subunit a was present at that position before oxidation (Fig. 2). If the labeling of c subunits with [14C]DCCD was random, then after oxidation, the single c subunit in the a–c band should contain ≈10% of the total 14C incorporated, assuming 10 copies of c per FO (13, 57). However, only a small increase in 14C was detected in the a–c band of oxidized samples (green trace). After subtracting the background radioactivity at the a–c position for a nonoxidized control, the a–c crosslinked product contained only 1.2% (±0.3) of the total 14C bound to c subunits. This value is 8-fold less than expected from random labeling of subunits within the c ring.
Table 2.
Treatment | Inhibition of ATPase (%)* | 14C-labeled c subunits [mol/mol FOF1]† |
---|---|---|
10 μM [14C]DCCD, 2 h | 74% (±5) | 1.8 (±0.2) |
100 μM [14C]DCCD, 0.5 h | 92% (±1) | 9.1 (±0.3) |
Inhibition was measured relative to a sample incubated in parallel without [14C]DCCD. Values for inhibition (±SD) are from six (10 μM) or three (100 μM) experiments. Note that treatment with 100 μM [14C]DCCD caused ∼5% direct inhibition of F1 activity, as measured in the presence of 0.5% lauryl dimethylamine oxide.
Distribution of 14C in SDS/PAGE samples was determined by PhosphorImager scanning (see Fig. 3). A low-level baseline was subtracted for the entire lane. Excluding the “free” [14C]DCCD peak, the sum of all significant peak areas is assumed to correspond to the total incorporated 14C determined by scintillation counting. For nonoxidized samples, the c peak accounted for 93% or 81% of total 14C incorporated after reaction with 10 or 100 μM [14C]DCCD, respectively. The standard deviations shown only reflect experimental reproducibility. Actual stoichiometries may have greater uncertainty due to errors in the measured FOF1 content of membranes, in the specific activity of the [14C]DCCD, in the assumed molecular weight of FOF1 (based on 10 c/mol), and in the method of background subtraction.
One trivial explanation for the low level of labeling of the a–c crosslinked product that would still be consistent with random labeling of c subunits would be that DCCD modification of cD61 prevents cM65C from crosslinking to aN214C. If this was the case, then the labeling of about 20% of the c subunits would result in a 20% decrease in the yield of the a–c crosslinked product. However, quantitation of subunit a in the a and a–c bands of immunoblots does not support this possibility. The crosslinking yield was decreased by less than 4% by labeling with 10 μM DCCD (Table 1). Furthermore, after treating membranes with 100 μM DCCD to label most of the c subunits (Table 2), the a–c crosslinking yield decreased by less than 20% (Table 1), whereas the 14C in the a–c band was ≈10-fold less than expected for random labeling of c subunits (data not shown). These results clearly indicate that the c subunit capable of forming the a–c crosslink is much less reactive toward DCCD than other c subunits in the c ring.
The asymmetric labeling of c subunits with [14C]DCCD thus allows the c subunit that can crosslink to subunit a to be distinguished from others in the c ring. Although DCCD modification of one or more c subunits inhibits rapid catalysis detectable by normal assays (Table 2 and ref. 58), it seemed plausible that conditions for ATP hydrolysis might drive a limited rotation of the c ring relative to subunit a and so bring a labeled c subunit into alignment with subunit a. Hence, membranes expressing aN214C/cM65C were treated with 10 μM [14C]DCCD to label about 2 c/FOF1 and then exposed to different conditions before oxidation to form the a–c crosslink. Fig. 3B compares the distribution of 14C on an SDS/PAGE gel for a labeled membrane sample that was divided and treated for 2 min with either MgADP/Pi (blue trace) or MgATP (red trace) before oxidation to form the a–c crosslink. Treatment with MgATP caused a significant increase in the amount of 14C present in the a–c band. To be certain that the increase was caused by an increase in 14C associated with the c subunit, a–c bands were extracted, reduced, and reanalyzed by SDS/PAGE. In the absence of ATP before oxidation, the a and c bands released from the a–c crosslink showed similar low levels of 14C. For the sample exposed to MgATP just before oxidation, the level of 14C in the a band was unchanged, but the c band showed a 2-fold increase (data not shown). Similar results were obtained by using FOF1 liposomes. Thus, the ATP-induced increase observed (Figs. 3B and 4) was caused by an increase in 14C-labeled c subunit in the a–c crosslinked product, indicating that a different c subunit had moved into alignment with subunit a.
The MgATP-dependent increase observed was less than one-fourth of that expected if catalysis-dependent rotation of the c ring had completely randomized the position of 14C-labeled c subunits relative to subunit a. Several factors may contribute to this less-than-maximal response. First, steric hindrance by the incorporated probe may kinetically limit the entry of labeled c subunits into the a/c interface. Second, a fraction of the FOF1 may be inhibited by MgADP and thus incapable of ATP-driven subunit rotation. Finally, only c rings with a single modified c subunit may have sufficient rotational mobility to move the labeled c into alignment with subunit a. The latter explanation is consistent with the fact that preincubation with 100 μM [14C]DCCD to modify most c subunits completely prevented the ATP effect (Fig. 3B, offset traces for the a–c peak).
Fig. 4 summarizes results from several experiments in which membranes were labeled by 10 μM [14C]DCCD. Consistently, the 14C present in the a–c crosslinked product was greater after exposure to MgATP. No such increase was seen after exposure to ADP/Pi or when samples were preincubated with inhibitory MgADP/azide before addition of MgATP. Hence, the movement of DCCD-labeled c subunits into the a/c interface requires conditions for ATP hydrolysis by FOF1.
Conditions for oxidative phosphorylation before crosslinking also were tested. However, in this case, no change in the 14C present in the a–c band was observed compared with the control (Fig. 4). H+-pumping assays done with aN214C/cM65C-membranes confirmed that succinate was an effective substrate for generating a transmembrane pH gradient, and vigorous aeration before crosslinking confirmed that oxygen was not limiting under conditions for oxidative phosphorylation (data not shown).
Discussion
The experiments presented here provide direct evidence that c subunits rotate relative to subunit a in membrane-bound FOF1. Although the approach used cannot show a complete or unidirectional cycle of rotation, the results are strongly supportive of energy coupling models that postulate direct rotary coupling between FO and F1, in which the rotor consists of the c ring plus γɛ and the stator of ab2δ plus α3β3 (Fig. 1). Furthermore, we show that subunit rotation at the a/c interface is energy-driven.
DCCD is a well-known inhibitor of the ATP synthase. Extensive modification of c subunits with 50 or 100 μM DCCD inhibits rotation of the c ring relative to subunit b (38), rotation of γ relative to α3β3 (28), and rotation of the c ring relative to subunit a (Fig. 3B, offset traces). Hence, at high labeling stoichiometries, DCCD appears to cause total seizure in the FO motor. Even at low labeling stoichiometries, DCCD inhibits catalytic activity measured by standard assays that have detection limits in the hundreds of ATP hydrolyzed per min per FOF1 (58). However, to detect subunit rotation by the approach used here, only one or two turnovers are required per FOF1 during the 2-min incubation with MgATP. Figs. 3 and 4 demonstrate that such limited subunit rotation can be driven by ATP hydrolysis when less than 20% of the c subunits are modified.
We were unable to demonstrate proton-driven subunit rotation under conditions for ATP synthesis. One possible explanation relates to the fact that ATP synthesis rates are typically much lower than ATPase rates for E. coli membranes (28, 59). Hence the lack of a detectable response may be due to the presence of a smaller fraction of active FOF1 complexes under ATP synthesis conditions. A second possibility relates to the fact that the c ring would be expected to rotate in the opposite direction from that obtained under ATP hydrolysis conditions. Hence a DCCD-modified c subunit may run into a greater physical barrier than that encountered when it enters the a/c interface from the other direction.
The asymmetric labeling of the c ring merits further comment. The c subunit capable of forming the aN214C-cM65C crosslink is strongly resistant to reaction with DCCD relative to other subunits in the c ring (Table 1, Fig. 3A). This may be the result of reduced access of DCCD to the a/c interface due to polarity and/or steric effects. Alternatively, because DCCD reacts with protonated carboxyls (60), the c subunit aligned to crosslink to subunit a may be in the deprotonated state. This would be consistent with a docking model for the a/c ring (45), in which aN214 is proximal to cM65 of the deprotonated c subunit.
Acknowledgments
We thank Dr. Robert Fillingame and his associates of the University of Wisconsin for both supplying antibodies and plasmids and for helpful discussions. We also thank Dr. Ron Kaback of the University of California, Los Angeles for suggesting I2 as an effective oxidant for membrane-embedded Cys and Drs. Yakov Milgrom and Vladimir Bulygin for helpful discussions. Ms. Pei Lin assisted in a number of preliminary experiments. This work was supported by Grant GM23152 from the National Institutes of Health, U.S. Public Health Service.
Abbreviations
- DCCD
N,N′-dicyclohexylcarbodiimide
- NEM
N-ethylmaleimide
References
- 1.Junge W. Proc Natl Acad Sci USA. 1999;96:4735–4737. doi: 10.1073/pnas.96.9.4735. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Fillingame R H, Jiang W, Dmitriev O Y, Jones P C. Biochim Biophys Acta. 2000;1458:387–403. doi: 10.1016/s0005-2728(00)00089-x. [DOI] [PubMed] [Google Scholar]
- 3.Kinosita K, Jr, Yasuda R, Noji H, Adachi K. Philos Trans R Soc London B. 2000;355:473–489. doi: 10.1098/rstb.2000.0589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Leslie A G, Walker J E. Philos Trans R Soc London. 2000;355:465–471. doi: 10.1098/rstb.2000.0588. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Oster G, Wang H. Biochim Biophys Acta. 2000;1458:482–510. doi: 10.1016/s0005-2728(00)00096-7. [DOI] [PubMed] [Google Scholar]
- 6.Foster D L, Fillingame R H. J Biol Chem. 1982;257:2009–2015. [PubMed] [Google Scholar]
- 7.Abrahams J P, Leslie A G, Lutter R, Walker J E. Nature (London) 1994;370:621–628. doi: 10.1038/370621a0. [DOI] [PubMed] [Google Scholar]
- 8.Bianchet M A, Hullihen J, Pedersen P L, Amzel L M. Proc Natl Acad Sci USA. 1998;95:11065–11070. doi: 10.1073/pnas.95.19.11065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Gibbons C, Montgomery M G, Leslie A G, Walker J E. Nat Struct Biol. 2000;7:1055–1061. doi: 10.1038/80981. [DOI] [PubMed] [Google Scholar]
- 10.Birkenhager R, Hoppert M, Deckers-Hebestreit G, Mayer F, Altendorf K. Eur J Biochem. 1995;230:58–67. [PubMed] [Google Scholar]
- 11.Takeyasu K, Omote H, Nettikadan S, Tokumasu F, Iwamoto-Kihara A, Futai M. FEBS Lett. 1996;392:110–113. doi: 10.1016/0014-5793(96)00796-x. [DOI] [PubMed] [Google Scholar]
- 12.Singh S, Turina P, Bustamante C J, Keller D J, Capaldi R A. FEBS Lett. 1996;397:30–34. doi: 10.1016/s0014-5793(96)01127-1. [DOI] [PubMed] [Google Scholar]
- 13.Stock D, Leslie A G, Walker J E. Science. 1999;286:1700–1705. doi: 10.1126/science.286.5445.1700. [DOI] [PubMed] [Google Scholar]
- 14.Zhang Y, Oldenburg M, Fillingame R H. J Biol Chem. 1994;269:10221–10224. [PubMed] [Google Scholar]
- 15.Zhang Y, Fillingame R H. J Biol Chem. 1995;270:24609–24614. [PubMed] [Google Scholar]
- 16.Watts S D, Tang C, Capaldi R A. J Biol Chem. 1996;271:28341–28347. doi: 10.1074/jbc.271.45.28341. [DOI] [PubMed] [Google Scholar]
- 17.Hermolin J, Dmitriev O Y, Zhang Y, Fillingame R H. J Biol Chem. 1999;274:17011–17016. doi: 10.1074/jbc.274.24.17011. [DOI] [PubMed] [Google Scholar]
- 18.Dimroth P. Biochim Biophys Acta. 1997;1318:11–51. doi: 10.1016/s0005-2728(96)00127-2. [DOI] [PubMed] [Google Scholar]
- 19.Boyer P D. Annu Rev Biochem. 1997;66:717–749. doi: 10.1146/annurev.biochem.66.1.717. [DOI] [PubMed] [Google Scholar]
- 20.Boyer P D. Biochim Biophys Acta. 1993;1140:215–250. doi: 10.1016/0005-2728(93)90063-l. [DOI] [PubMed] [Google Scholar]
- 21.Boyer P D, Cross R L, Momsen W. Proc Natl Acad Sci USA. 1973;70:2837–2839. doi: 10.1073/pnas.70.10.2837. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kayalar C, Rosing J, Boyer P D. J Biol Chem. 1977;252:2486–2491. [PubMed] [Google Scholar]
- 23.Boyer P D, Kohlbrenner W E. In: Energy Coupling in Photosynthesis. Selman B, Selman-Reiner S, editors. New York: Elsevier/North–Holland; 1981. pp. 231–240. [Google Scholar]
- 24.Duncan T M, Bulygin V V, Zhou Y, Hutcheon M L, Cross R L. Proc Natl Acad Sci USA. 1995;92:10964–10968. doi: 10.1073/pnas.92.24.10964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Sabbert D, Engelbrecht S, Junge W. Nature (London) 1996;381:623–625. doi: 10.1038/381623a0. [DOI] [PubMed] [Google Scholar]
- 26.Noji H, Yasuda R, Yoshida M, Kinosita K., Jr Nature (London) 1997;386:299–302. doi: 10.1038/386299a0. [DOI] [PubMed] [Google Scholar]
- 27.Zhou Y, Duncan T M, Bulygin V V, Hutcheon M L, Cross R L. Biochim Biophys Acta. 1996;1275:96–100. doi: 10.1016/0005-2728(96)00056-4. [DOI] [PubMed] [Google Scholar]
- 28.Zhou Y, Duncan T M, Cross R L. Proc Natl Acad Sci USA. 1997;94:10583–10587. doi: 10.1073/pnas.94.20.10583. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kato-Yamada Y, Noji H, Yasuda R, Kinosita K, Jr, Yoshida M. J Biol Chem. 1998;273:19375–19377. doi: 10.1074/jbc.273.31.19375. [DOI] [PubMed] [Google Scholar]
- 30.Bulygin V V, Duncan T M, Cross R L. J Biol Chem. 1998;273:31765–31769. doi: 10.1074/jbc.273.48.31765. [DOI] [PubMed] [Google Scholar]
- 31.Howitt S M, Rodgers A J, Hatch L P, Gibson F, Cox G B. J Bioenerg Biomembr. 1996;28:415–420. doi: 10.1007/BF02113983. [DOI] [PubMed] [Google Scholar]
- 32.Vik S B, Long J C, Wada T, Zhang D. Biochim Biophys Acta. 2000;1458:457–466. doi: 10.1016/s0005-2728(00)00094-3. [DOI] [PubMed] [Google Scholar]
- 33.Cross R L. Biochim Biophys Acta. 2000;1458:270–275. doi: 10.1016/s0005-2728(00)00079-7. [DOI] [PubMed] [Google Scholar]
- 34.Schulenberg B, Aggeler R, Murray J, Capaldi R A. J Biol Chem. 1999;274:34233–34237. doi: 10.1074/jbc.274.48.34233. [DOI] [PubMed] [Google Scholar]
- 35.Tsunoda S P, Aggeler R, Yoshida M, Capaldi R A. Proc Natl Acad Sci USA. 2001;98:898–902. doi: 10.1073/pnas.031564198. . (First Published January 23, 2001; 10.1073/pnas.031564198) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Sambongi Y, Iko Y, Tanabe M, Omote H, Iwamoto-Kihara A, Ueda I, Yanagida T, Wada Y, Futai M. Science. 1999;286:1722–1724. doi: 10.1126/science.286.5445.1722. [DOI] [PubMed] [Google Scholar]
- 37.Tsunoda S P, Aggeler R, Noji H, Kinosita K, Yoshida M, Capaldi R A. FEBS Lett. 2000;470:244–248. doi: 10.1016/s0014-5793(00)01336-3. [DOI] [PubMed] [Google Scholar]
- 38.Jones P C, Hermolin J, Jiang W, Fillingame R H. J Biol Chem. 2000;275:31340–31346. doi: 10.1074/jbc.M003687200. [DOI] [PubMed] [Google Scholar]
- 39.Hartzog P E, Cain B D. J Biol Chem. 1994;269:32313–32317. [PubMed] [Google Scholar]
- 40.Cox G B, Devenish R J, Gibson F, Howitt S M, Nagley P. In: Molecular Mechanisms in Bioenergetics. Ernster L, editor. New York: Elsevier; 1992. pp. 283–315. [Google Scholar]
- 41.Vik S B, Antonio B J. J Biol Chem. 1994;269:30364–30369. [PubMed] [Google Scholar]
- 42.Junge W, Lill H, Engelbrecht S. Trends Biochem Sci. 1997;22:420–423. doi: 10.1016/s0968-0004(97)01129-8. [DOI] [PubMed] [Google Scholar]
- 43.Jiang W, Fillingame R H. Proc Natl Acad Sci USA. 1998;95:6607–6612. doi: 10.1073/pnas.95.12.6607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Dimroth P, Wang H, Grabe M, Oster G. Proc Natl Acad Sci USA. 1999;96:4924–4929. doi: 10.1073/pnas.96.9.4924. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Rastogi V K, Girvin M E. Nature (London) 1999;402:263–268. doi: 10.1038/46224. [DOI] [PubMed] [Google Scholar]
- 46.Hermolin J, Fillingame R H. J Biol Chem. 1995;270:2815–2817. doi: 10.1074/jbc.270.6.2815. [DOI] [PubMed] [Google Scholar]
- 47.Girvin M E, Hermolin J, Pottorf R, Fillingame R H. Biochemistry. 1989;28:4340–4343. doi: 10.1021/bi00436a032. [DOI] [PubMed] [Google Scholar]
- 48.Wise J G. J Biol Chem. 1990;265:10403–10409. [PubMed] [Google Scholar]
- 49.Gibson F, Downie J A, Cox G B, Radik J. J Bacteriol. 1978;134:728–736. doi: 10.1128/jb.134.3.728-736.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Gibson F, Cox G B, Downie J A, Radik J. Biochem J. 1977;162:665–670. doi: 10.1042/bj1620665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Laemmli U K. Nature (London) 1970;227:680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
- 52.Peterson G L. Anal Biochem. 1977;83:346–356. doi: 10.1016/0003-2697(77)90043-4. [DOI] [PubMed] [Google Scholar]
- 53.Lotscher H R, deJong C, Capaldi R A. Biochemistry. 1984;23:4140–4143. doi: 10.1021/bi00313a020. [DOI] [PubMed] [Google Scholar]
- 54.Watts S D, Capaldi R A. J Biol Chem. 1997;272:15065–15068. doi: 10.1074/jbc.272.24.15065. [DOI] [PubMed] [Google Scholar]
- 55.Kimura T, Suzuki M, Sawai T, Yamaguchi A. Biochemistry. 1996;35:15896–15899. doi: 10.1021/bi961568g. [DOI] [PubMed] [Google Scholar]
- 56.Jones P C, Jiang W, Fillingame R H. J Biol Chem. 1998;273:17178–17185. doi: 10.1074/jbc.273.27.17178. [DOI] [PubMed] [Google Scholar]
- 57.Jiang W, Hermolin J, Fillingame R H. Proc Natl Acad Sci USA. 2001;98:4966–4971. doi: 10.1073/pnas.081424898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Hermolin J, Fillingame R H. J Biol Chem. 1989;264:3896–3903. [PubMed] [Google Scholar]
- 59.Al-Shawi M K, Nakamoto R K. Biochemistry. 1997;36:12954–12960. doi: 10.1021/bi971477z. [DOI] [PubMed] [Google Scholar]
- 60.Lundblad R L. Chemical Reagents for Protein Modification. 2nd Ed. Boca Raton, FL: CRC; 1991. [Google Scholar]